File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1084/jem.186.7.989
- Scopus: eid_2-s2.0-1842289172
- PMID: 9314549
- WOS: WOS:A1997YA58000003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice
Title | Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice |
---|---|
Authors | |
Issue Date | 1997 |
Citation | Journal of Experimental Medicine, 1997, v. 186, n. 7, p. 989-997 How to Cite? |
Abstract | To investigate the role oft cell-mediated, perforin-dependent cytotoxicity in autoimmune diabetes, perforin-deficient mice were backcrossed with the nonobese diabetes mouse strain. It was found that the incidence of spontaneous diabetes over a 1 yr period was reduced from 77% in perforin +/+ control to 16% in perforin-deficient mice. Also, the disease onset was markedly delayed (median onset of 39.5 versus 19 wk) in the latter. Insulitis with infiltration of CD4+ and CD8+ T cells occurred similarly in both groups of animals. Lower incidence and delayed disease onset were also evident in perforin-deficient mice when diabetes was induced by cyclophosphamide injection. Thus, perforin-dependent cytotoxicity is a crucial effector mechanism for β cell elimination by cytotoxic T cells in autoimmune diabetes. However, in the absence of perforin chronic inflammation of the islets can lead to diabetogenic β cell loss by less efficient secondary effector mechanisms. |
Persistent Identifier | http://hdl.handle.net/10722/291719 |
ISSN | 2023 Impact Factor: 12.6 2023 SCImago Journal Rankings: 6.838 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kägi, David | - |
dc.contributor.author | Odermatt, Bernhard | - |
dc.contributor.author | Seiler, Peter | - |
dc.contributor.author | Zinkernagel, Rolf M. | - |
dc.contributor.author | Mak, Tak W. | - |
dc.contributor.author | Hengartner, Hans | - |
dc.date.accessioned | 2020-11-17T14:54:58Z | - |
dc.date.available | 2020-11-17T14:54:58Z | - |
dc.date.issued | 1997 | - |
dc.identifier.citation | Journal of Experimental Medicine, 1997, v. 186, n. 7, p. 989-997 | - |
dc.identifier.issn | 0022-1007 | - |
dc.identifier.uri | http://hdl.handle.net/10722/291719 | - |
dc.description.abstract | To investigate the role oft cell-mediated, perforin-dependent cytotoxicity in autoimmune diabetes, perforin-deficient mice were backcrossed with the nonobese diabetes mouse strain. It was found that the incidence of spontaneous diabetes over a 1 yr period was reduced from 77% in perforin +/+ control to 16% in perforin-deficient mice. Also, the disease onset was markedly delayed (median onset of 39.5 versus 19 wk) in the latter. Insulitis with infiltration of CD4+ and CD8+ T cells occurred similarly in both groups of animals. Lower incidence and delayed disease onset were also evident in perforin-deficient mice when diabetes was induced by cyclophosphamide injection. Thus, perforin-dependent cytotoxicity is a crucial effector mechanism for β cell elimination by cytotoxic T cells in autoimmune diabetes. However, in the absence of perforin chronic inflammation of the islets can lead to diabetogenic β cell loss by less efficient secondary effector mechanisms. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Experimental Medicine | - |
dc.title | Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice | - |
dc.type | Article | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1084/jem.186.7.989 | - |
dc.identifier.pmid | 9314549 | - |
dc.identifier.pmcid | PMC2199062 | - |
dc.identifier.scopus | eid_2-s2.0-1842289172 | - |
dc.identifier.volume | 186 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 989 | - |
dc.identifier.epage | 997 | - |
dc.identifier.isi | WOS:A1997YA58000003 | - |
dc.identifier.issnl | 0022-1007 | - |